初级保健提供者推模式和对非控制性喘生物治疗的认识
Juan Carlos Cardet1, Bijalben Patel2, Phuong Bradford3
1Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida, Morsani College of Medicine, Tampa, Fla.
The journal of allergy and clinical immunology. Global
|January 16, 2026
概括
初级保健提供者经常推迟对失控喘的转诊,并且缺乏对生物疗法的熟悉. 在初级保健提供者和专家之间改善教育和沟通可以帮助减少喘恶化.
科学领域:
- 肺部病理学 肺部病理学
- 主要护理医学 医疗保健
- 临床研究 临床研究
背景情况:
- 喘是一种慢性呼吸道疾病,导致严重的发病率.
- 在美国,大多数不受控制的喘病例是由初级保健提供者 (PCP) 管理的,而不是喘专家.
- 喘专家对先进的治疗方法比较了解,比如减少恶化症状的生物药物.
研究的目的:
- 检查初级保健提供者向喘专家的转诊模式.
- 评估PCP对喘生物疗法的熟悉程度.
- 调查PCP在喘管理中的实验室测试的使用情况.
主要方法:
- 一项横截面调查分发给美国47个州的404个PCP.
- 描述性统计分析了受访者特征.
- 双变量和多变量分析确定了与转诊模式,生物熟悉性和实验室测试使用相关的因素.
主要成果:
- 超过50%的PCP推迟了对不受控制的喘的转诊,直到每年出现3个以上的恶化.
- 近33%的PCP对喘生物疗法不熟悉.
- 超过70%的PCP没有定期使用实验室测试来治疗喘.
结论:
- PCP经常推迟专家推,并未充分利用用于喘管理的实验室测试.
- 很大一部分PCP缺乏关于先进的喘治疗方法 (如生物药物) 的知识.
- 加强PCP专家沟通和对喘治疗的教育对于减少喘恶化至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K


